Assessing Knowledge, Beliefs and Attitudes Toward HPV Vaccination Among Parents in North West, Cameroon
NCT05325138 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 45
Last updated 2022-04-13
Summary
The aim of this study is to assess knowledge, beliefs and attitudes of parents to young girls aged 9 to 14 years about HPV vaccines within some rural communities in the North West Region of Cameroon served by three hospitals in that area. To do this, we will conduct in-depth qualitative interviews with purposively sampled parents of girls aged 9 to 14 years, some of whom received HPV vaccine and some of whom did not. Interviews will continue until thematic saturation is reached (We anticipate a total 40 interviews). Data analysis will be done concurrently with interviews using thematic analysis.
Conditions
- Vaccine Refusal
Interventions
- OTHER
-
Interview
Parents of girls aged 9-14yearsold will undergo an interview to determine their knowledge, attitudes and beliefs concerning HPV vaccination
Sponsors & Collaborators
-
Merck Canada Inc.
collaborator INDUSTRY - lead OTHER
Principal Investigators
-
Lorraine M Elit, MD MSc · McMaster University
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-03-14
- Primary Completion
- 2023-01-31
- Completion
- 2023-01-31
Countries
- Cameroon
Study Locations
More Related Trials
-
A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine
NCT00501137 ·Status: COMPLETED ·Phase: PHASE3
-
HPV Vaccine in Postpartum Women
NCT04430907 ·Status: WITHDRAWN
-
HPV Prevalence in 16-20 Year Old Males
NCT04297670 ·Status: UNKNOWN
-
The Acceptability of the HPV Vaccine Postpartum and With Pediatric Well-child Visits: A Pilot Study
NCT02602626 ·Status: COMPLETED
-
Vaccine Social Media Randomized Intervention Trial
NCT01873040 ·Status: COMPLETED ·Phase: NA
-
Testing The Effectiveness Of Two Interventions To Reduce Vaccine Hesitancy Among Adolescents
NCT06155877 ·Status: COMPLETED ·Phase: NA
-
A Study to Gather Safety Data Following Administration of a Hib-containing Booster Vaccine in Children Aged Two to Five Years
NCT00625118 ·Status: COMPLETED
-
Safety and Immune Response of Different Pediatric Combination Vaccines.
NCT00255047 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate the Safety and Primary Immunogenicity of Cell-free (Three-component) Combination Vaccine for Phase I Immunogenicity in Children and Infants
NCT05189548 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Making Decisions About the Measles-Mumps-Rubella Vaccine
NCT01369394 ·Status: COMPLETED ·Phase: NA
-
Social Media-based Vaccine Confidence and Hesitancy Monitoring
NCT05442762 ·Status: WITHDRAWN
-
Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years.
NCT00326118 ·Status: COMPLETED ·Phase: PHASE3
-
the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines
NCT07338851 ·Status: NOT_YET_RECRUITING
-
DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants
NCT02817451 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants
NCT01444781 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Infants and Children
NCT01428908 ·Status: COMPLETED ·Phase: PHASE3
-
IPV Clinical Trial - The Gambia
NCT01847872 ·Status: COMPLETED ·Phase: PHASE4
-
An RCT Promoting HPV Vaccination Among Chinese MSM
NCT03286907 ·Status: COMPLETED ·Phase: NA
-
Zambia SiVET MMR Tdap-IPV
NCT02589678 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers
NCT04535037 ·Status: COMPLETED ·Phase: PHASE4
-
Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the Philippines
NCT01738841 ·Status: WITHDRAWN
-
Clinic Trial to Evaluate the Safety and Immunogenicity by Different Sequential Schedules of bOPV and IPV
NCT03614702 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants
NCT00287092 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study on the Combined Administration of 15-Valent Pneumococcal Conjugate Vaccine and Diphtheria, Tetanus, Pertussis Vaccine
NCT06817187 ·Status: COMPLETED ·Phase: PHASE3
-
Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Children
NCT01406509 ·Status: COMPLETED ·Phase: PHASE1